Mouse Anti-Human IFN alpha
Slide this table
| Cat-Nr. | 101-M02 |
| Size | 500 µg |
| Price | 275 € |
| Category | Monoclonal Antibody |
| Isotype | IgG1, kappa |
| Species Reactivity | Human |
| Formulation | lyophilized from PBS |
| Buffer | PBS |
| Reconstitution | Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml. |
| Stability and Storage | The lyophilized antibody is stable for at least 2 years from date of receipt at -20°C. The reconstituted antibody is stable for at least two weeks at 2-8°C. Frozen aliquots are stable for at least 6 months when stored at -20°C. |
| Preparation | Produced in BALB/c x ICR F1 mice using recombinant human IFN- as the immunizing antigen. IgG1 antibody was purified from ascites fluid on a Protein A affinity column. |
| Antigen | Recombinant human IFN-alpha |
| Application | ELISA |
| Synonyms | IFNA1; IFL; IFN; IFNA; IFNA13; IFN-ALPHA; IFN-alphaD; Interferon |
| Description | Interferon-alpha (IFN-alpha), also known as leukocyte interferon, represents a group of related but distinct proteins that share over 95% amino acid sequence homology. They are members of the type I interferon family which share a common cell surface receptor composed of two subunits, a 100 kDa ligand-binding subunit (IFN-alpha R2) and a 125 kDa ligand binding and signal transduction subunit (IFN-alpha R1) that is involved both in ligand binding and signal transduction. IFN-alpha has both anti-viral and immunomodulatory activities on target cells. |
| Uniprot ID | P01562 |
| Protein RefSeq | NP_076918.1 |
| mRNA RefSeq | NM_024013.1 |
Reference
- Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells. M. Nakano et al., Clin Exp Immunol. 2012 Oct; 170(1): 94–100.
All prices plus VAT + possible delivery charges